Drug intelligence / Profile preview

Nightex

Development stage: Unknown
Lead developer: Ergon Pharmaceuticals
Administration: Oral

Overview

**Nightex** is a marketed Bangladeshi Ayurvedic capsule product from **Ergon Pharmaceuticals**. The manufacturer lists it as a 500 mg preparation of **Ratibilas Bati**, a traditional herbal formulation. It is marketed for male sexual weakness and libido-related concerns. Its exact botanical composition, molecular targets, and evidence-based pharmacologic mechanism are not publicly specified in the identified manufacturer materials.

Brand names: Night ExNightex
Other names: Ratibilas Bati

Beyond the preview

Go deeper on Nightex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nightex.

Explore the full profile